It’s one of the many reasons why researchers don’t release results as a trickle.
Lets say Drug A is being investigated for efficacy.
And it shows a positive result in 15% of 100 subjects tested.
If the first fifteen patients all responded, then the next eighty-five didn’t, yet they released the results after the first fifteen...you get the idea.
A case-study would be level IV evidence in the UK, compared to an RCT being Ib. The highest level, Ia, being afforded to systemic reviews of multiple RCTs.
It’s one of the many reasons why researchers don’t release...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
